Anna Eitenmüller, Lisa Piano, Myriam Böhm, Kija Shah-Hosseini, Andreas Glowania, Oliver Pfaar, Ralph Mösges, Ludger Klimek
Objective. To investigate the tolerability and impact on quality of life of liposomal nasal spray compared to guideline-recommended steroid-based therapy in patients with chronic rhinosinusitis. Symptom reduction and use of antisymptomatic medication were also examined. Methods. In this monocenter, prospective, controlled, open, and noninterventional study, 60 patients with chronic rhinosinusitis were treated with liposomal nasal spray and 30 patients received steroid-based therapy. The study comprised five visits occurring at intervals of two to four weeks...
2014: Journal of Allergy